The global demand for Aortic Aneurysm Market is presumed to reach the market size of nearly USD 18.5 BN by 2030 from USD 6.1 BN in 2022 with a CAGR of 13.12% under the study period 2023-2030.
An aortic aneurysm refer to an abnormal bulge or swelling in the wall of the aorta, which is the largest artery in the body. This type of swelling can occur in any part of the aorta but are most commonly found in the abdominal and thoracic areas. Aortic aneurysms can be classified as either fusiform, which involves a gradual bulging of the aortic wall, or saccular, which involves a more localized bulging. Aneurysms can also be classified by size, with larger aneurysms posing a higher risk of rupture. Aortic aneurysms are often asymptomatic, which means that people may not know they have one until it is discovered during medical imaging tests for other reasons. However, in some cases, aneurysms can cause symptoms such as back pain, chest pain, abdominal pain, or shortness of breath.
The prevalence of aortic aneurysms is increasing globally due to various factors such as the aging population, high blood pressure, obesity, smoking, and other lifestyle factors. This is driving the growth of the market. Advances in medical technologies are making it easier and safer to diagnose and treat aortic aneurysms. For example, minimally invasive surgical techniques such as endovascular aneurysm repair (EVAR) and thoracic endovascular aortic repair (TEVAR) are becoming more widely available, making treatment more accessible to patients. The growing awareness about the risks and consequences of aortic aneurysms is driving demand for diagnosis and treatment. Increased public education campaigns about the condition are helping to raise awareness about the disease. The increase in healthcare expenditure by governments and private organizations is driving the growth of the aortic aneurysm market. This is due to the higher availability of funds for research and development and increasing investments by pharmaceutical and medical device companies to develop new treatment options. The growing geriatric population is a significant driver of the aortic aneurysm market. This demographic group is at higher risk for developing the disease, and their increasing numbers are contributing to the overall growth of the market. The incidence of co-morbid conditions such as diabetes and hypertension, which are linked to a higher risk of developing aortic aneurysms, is also driving the growth of the market. As the incidence of these conditions rises, so does the prevalence of aortic aneurysms.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of aortic aneurysm. The growth and trends of aortic aneurysm industry provide a holistic approach to this study.
This section of the aortic aneurysm market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
- Thoracic Aortic Aneurysm (TAA)
- Abdominal Aortic Aneurysm (AAA)
- Open Surgical Repair (OSR)
- Endovascular Aneurysm Repair (EVAR)
By End User
- Ambulatory Surgery Centers
This section covers the regional outlook, which accentuates current and future demand for the Aortic Aneurysm market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Aortic Aneurysm Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the aortic aneurysm market include Medtronic, Endologix LLC, Gore Medical, MicroPort Scientific Corporation, Cook, JOTEC, Cardinal Health, Terumo Corporation, Lombard Medical, AbbVie Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.